Physician profile
Yan Li
NPI 1629521042
$641.09
in general payments reported to CMS, 2019-2025
7 companies · $59.99 in 2025
The $59.99 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.29 · 2020: $135 · 2021: $44.44 · 2022: $102 · 2023: $127 · 2024: $108 · 2025: $59.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235 · Education: $59.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.64 |
| Education | $59.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $253.35 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $117.11 | 2020 | |
| Merck Sharp & Dohme LLC | $82.02 | 2019-2024 | Verquvo, Zerbaxa |
| Janssen Biotech, INC. | $59.99 | 2025 | Tremfya |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.90 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $49.48 | 2019-2024 | Andexxa |
| Ucb, INC. | $25.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.